1. Home
  2. NLSP vs MMA Comparison

NLSP vs MMA Comparison

Compare NLSP & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • MMA
  • Stock Information
  • Founded
  • NLSP 2015
  • MMA 2013
  • Country
  • NLSP Switzerland
  • MMA Australia
  • Employees
  • NLSP N/A
  • MMA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • MMA
  • Sector
  • NLSP Health Care
  • MMA
  • Exchange
  • NLSP Nasdaq
  • MMA Nasdaq
  • Market Cap
  • NLSP 12.4M
  • MMA 13.4M
  • IPO Year
  • NLSP 2021
  • MMA 2024
  • Fundamental
  • Price
  • NLSP $2.68
  • MMA $1.40
  • Analyst Decision
  • NLSP
  • MMA
  • Analyst Count
  • NLSP 0
  • MMA 0
  • Target Price
  • NLSP N/A
  • MMA N/A
  • AVG Volume (30 Days)
  • NLSP 325.4K
  • MMA 426.1K
  • Earning Date
  • NLSP 07-07-2025
  • MMA 01-21-2025
  • Dividend Yield
  • NLSP N/A
  • MMA N/A
  • EPS Growth
  • NLSP N/A
  • MMA N/A
  • EPS
  • NLSP N/A
  • MMA N/A
  • Revenue
  • NLSP N/A
  • MMA $407,412.00
  • Revenue This Year
  • NLSP N/A
  • MMA N/A
  • Revenue Next Year
  • NLSP N/A
  • MMA N/A
  • P/E Ratio
  • NLSP N/A
  • MMA N/A
  • Revenue Growth
  • NLSP N/A
  • MMA N/A
  • 52 Week Low
  • NLSP $1.30
  • MMA $0.60
  • 52 Week High
  • NLSP $16.00
  • MMA $4.11
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 62.59
  • MMA N/A
  • Support Level
  • NLSP $2.19
  • MMA N/A
  • Resistance Level
  • NLSP $2.54
  • MMA N/A
  • Average True Range (ATR)
  • NLSP 0.19
  • MMA 0.00
  • MACD
  • NLSP -0.01
  • MMA 0.00
  • Stochastic Oscillator
  • NLSP 57.89
  • MMA 0.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

Share on Social Networks: